Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Janet Freilich

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Science (New York, N.Y.)|June 15, 2019
Science fiction: Fictitious experiments in patentsJanet Freilich, Lisa Larrimore Ouellette
JAMA|September 18, 2024
The Patent Trial and Appeals Board: A Target for Prescription Drug Patent Reform?Janet Freilich, Aaron S Kesselheim
Nature Biotechnology|March 18, 2026
Patents on AI-derived drugs: empirical evidence and legal challengesJanet Freilich, Arti K Rai
Applied Health Economics and Health Policy|April 8, 2025
Design Patents: A Potential Threat to Drug CompetitionJanet Freilich, Aaron S Kesselheim
Lancet (London, England)|July 6, 2025
Data manipulation within the US Federal GovernmentJanet Freilich, Aaron S Kesselheim
Clinical Pharmacology and Therapeutics|March 28, 2025
Frequency and Nature of Generic "Design Around" of Brand-Name Patents in the United StatesJanet Freilich, Aaron S Kesselheim
The New England Journal of Medicine|March 26, 2025
Disappearing Data at the U.S. Federal GovernmentJanet Freilich, W Nicholson Price, Aaron S Kesselheim
Annals of Internal Medicine|January 26, 2026
Unexplained Pauses in Centers for Disease Control and Prevention Surveillance: Erosion of the Public Evidence Base for Health PolicyJeremy W Jacobs, Garrett S Booth, Noel T Brewer, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Science (New York, N.Y.)|June 15, 2019
Science fiction: Fictitious experiments in patentsJanet Freilich, Lisa Larrimore Ouellette
JAMA|September 18, 2024
The Patent Trial and Appeals Board: A Target for Prescription Drug Patent Reform?Janet Freilich, Aaron S Kesselheim
Nature Biotechnology|March 18, 2026
Patents on AI-derived drugs: empirical evidence and legal challengesJanet Freilich, Arti K Rai
Applied Health Economics and Health Policy|April 8, 2025
Design Patents: A Potential Threat to Drug CompetitionJanet Freilich, Aaron S Kesselheim
Lancet (London, England)|July 6, 2025
Data manipulation within the US Federal GovernmentJanet Freilich, Aaron S Kesselheim
Clinical Pharmacology and Therapeutics|March 28, 2025
Frequency and Nature of Generic "Design Around" of Brand-Name Patents in the United StatesJanet Freilich, Aaron S Kesselheim
The New England Journal of Medicine|March 26, 2025
Disappearing Data at the U.S. Federal GovernmentJanet Freilich, W Nicholson Price, Aaron S Kesselheim
Annals of Internal Medicine|January 26, 2026
Unexplained Pauses in Centers for Disease Control and Prevention Surveillance: Erosion of the Public Evidence Base for Health PolicyJeremy W Jacobs, Garrett S Booth, Noel T Brewer, et al.
Pageof 1